Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 3Phase 3 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Vomiting 1Solid Tumors 1Nausea 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Metoclopramide × Clear all
NCT02135510 2020-03-31

MEDEA

Amsterdam UMC, location VUmc

Phase 3 Completed
249 enrolled
Other solid neoplasm

Solid Tumors

NCT00003213 2012-07-11

Drugs to Reduce the Side Effects of Chemotherapy

Swiss Cancer Institute

Phase 3 Completed
267 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡